Heart Regeneration Technologies GmbH, by Avenns Medical

Heart Regeneration Technologies GmbH, by Avenns Medical

Heart Regeneration becomes Reality!

Description: Heart Regeneration Technologies GmbH, by Avenns Medical, focuses on the regeneration of infarcted heart muscle, a significant challenge in modern medicine. The company's approach involves shockwave therapy, which has shown promising results in inducing tissue regeneration and improving heart function. Unlike traditional stem cell and gene therapy, shockwave therapy has a proven safety record over more than 30 years, making it a unique and compelling regenerative therapy approach.

Founded: 2016

Headquarter: Austria

Last Investment: Pre Seed Round investment at 02 July 2017

Last Investment Investors: TBA Tyrolean Business Angel

Heart Regeneration Technologies GmbH presents an innovative and potentially disruptive approach to addressing heart muscle regeneration, backed by a solid track record in other medical indications. The company's efforts in developing an intraoperative and minimally-invasive cardiac shockwave therapy could potentially revolutionize the treatment of heart-related conditions, presenting an exciting opportunity for investors in the healthcare sector.